Market revenue in 2023 | USD 40.6 million |
Market revenue in 2030 | USD 71.4 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Botulinum toxin |
Fastest growing segment | Hyaluronic Acid |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.81% in 2023. Horizon Databook has segmented the Norway aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing emphasis on beauty and aesthetics and a growing desire for youthful appearance are expected to drive the demand for aesthetic injectables in Norway. Furthermore, the country’s reputation for high quality healthcare and cosmetic procedures may attract medical tourists seeking aesthetic injectables.
This is expected to contribute to industry growth by bringing in international clientele. Growing mental health awareness is significantly boosting the market. According to an article published in October 2022, the demand for aesthetic injectables in Norway is experiencing a notable upswing due to a unique connection between mental health & the desire for cosmetic enhancements.
Recent studies reveal that individuals experiencing symptoms of mental disorders, such as depression & anxiety, are more inclined toward cosmetic procedures, including those involving dermal fillers. This points to a heightened understanding in Norway that links mental wellbeing with aesthetic choices.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into Norway aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account